PAIARDI, GIULIA
PAIARDI, GIULIA
Dipartimento di Medicina Molecolare e Traslazionale
A Bittersweet Computational Journey among Glycosaminoglycans
2021-01-01 Paiardi, Giulia; Milanesi, Maria; Wade, Rebecca C.; D’Ursi, Pasqualina; Rusnati, Marco
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin
2021-01-01 Rusnati, M.; Paiardi, G.; Tobia, C.; Urbinati, C.; Lodola, A.; D'Ursi, P.; Corrado, M.; Castelli, R.; Wade, R. C.; Tognolini, M.; Chiodelli, P.
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2
2024-01-01 Milanesi, Maria; Urbinati, Chiara; Zimmermann, Liv; Oreste, Pasqua; Caccuri, Francesca; Chlandal, Petr; Wade, Rebecca C.; Paiardi, Giulia; Marco Rusnati, And
direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound
2019-01-01 Chiodelli, P.; Paiardi, G.; Urbinati, C.; Lodola, A.; Tognolini, M.; D'Ursi, P.; Corrado, M.; Rusnati, M.
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue
2019-01-01 D'Ursi, P.; Uggeri, M.; Urbinati, C.; Millo, E.; Paiardi, G.; Milanesi, L.; Ford, R. C.; Clews, J.; Meng, X.; Bergese, P.; Ridolfi, Andrea; Pedemonte, N.; Fossa, P.; Orro, A.; Rusnati, M.
Glycan-Protein interactions in pathological processes: development of new molecular and cellular models for glycobiology-oriented studies
2021-03-25 Paiardi, Giulia
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications
2019-01-01 Bugatti, Antonella; Paiardi, Giulia; Urbinati, Chiara; Chiodelli, Paola; Orro, Alessandro; Uggeri, Matteo; Milanesi, Luciano; Caruso, Arnaldo; Caccuri, Francesca; D'Ursi, Pasqualina; Rusnati, Marco
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications
2019-01-01 Paiardi, G.; Bugatti, A.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Caruso, A.; Caccuri, F.; D'Ursi, P.; Rusnati, M.
Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryos
2024-01-01 Guerra, Jessica; Belleri, Mirella; Paiardi, Giulia; Tobia, Chiara; Capoferri, Davide; Corli, Marzia; Scalvini, Elisa; Ghirimoldi, Marco; Manfredi, Marcello; Wade, Rebecca C.; Presta, Marco; Mignani, Luca
implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study
2019-01-01 Paiardi, G.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Milanesi, L.; D'Ursi, P.; Rusnati, M.
implementation of an incremental docking method to study long sugar chains interactions with proteins
2019-01-01 Paiardi, G.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Milanesi, L.; Rusnati, M.; D'Ursi, P.
Iron absorption in celiac disease and nutraceutical effect of 7-hydroxymatairesinol. Mini-review
2020-01-01 Zanella, I.; Paiardi, G.; D'Antiga, Lorenzo; Biasiotto, G.
moelcular dynamics simulations to investigate the antiviral effect of heparin in SARS-CoV-2 spike infection
2021-01-01 Paiardi, G.; Richter, S.; Rusnati, M.; Wade, r. c.
Molecular dynamics simulations to investigate the dynamics and mechanism of action of carbohydrate-based polymers
2022-01-01 Paiardi, G; Mukherjee, G; Richter, S; Oreste, P; Urbinati, C; Mukesh, S; Singh, R; Steenbuck, N; Demidova, C; Joshi, P; Rusnati, M; Sangamwar, At; Wade, Rc
multidisciplinary approaches to rescue CFTR impairments by drug repositioning
2019-01-01 Uggeri, M.; Orro, A.; Urbinati, C.; Millo, E.; Paiardi, G.; Milanesi, L.; Pedemonte, N.; Fossa, P.; Rusnati, M.; D'Ursi, P.
rescuing defective CFTR applying a drug repositioning strategy
2019-01-01 Uggeri, M.; Orro, A.; Millo, E.; Cichero, E.; Paiardi, G.; Milanesi, L.; Pedemonte, N.; Rusnati, M.; D'Ursi, P.; Fossa, P.
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays
2018-01-01 D'Ursi, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Paiardi, G.; Millo, E.; Milanesi, L.; Fossa, P.; Rusnati, M.
rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays
2019-01-01 D'Ursi, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Paiardi, G.; Millo, E.; Milanesi, L.; Pedemonte, N.; Fossa, P.; Rusnati, M.
Sialic acid as a target for the development of novel antiangiogenic strategies
2018-01-01 Chiodelli, Paola; Urbinati, Chiara; Paiardi, Giulia; Monti, Eugenio; Rusnati, Marco
Specific profile of ultrasonic communication in a mouse model of neurodevelopmental disorders
2019-01-01 Premoli, M.; Bonini, S. A.; Mastinu, A.; Maccarinelli, G.; Aria, F.; Paiardi, G.; Memo, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Bittersweet Computational Journey among Glycosaminoglycans | 1-gen-2021 | Paiardi, Giulia; Milanesi, Maria; Wade, Rebecca C.; D’Ursi, Pasqualina; Rusnati, Marco | |
| Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin | 1-gen-2021 | Rusnati, M.; Paiardi, G.; Tobia, C.; Urbinati, C.; Lodola, A.; D'Ursi, P.; Corrado, M.; Castelli, R.; Wade, R. C.; Tognolini, M.; Chiodelli, P. | |
| Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 | 1-gen-2024 | Milanesi, Maria; Urbinati, Chiara; Zimmermann, Liv; Oreste, Pasqua; Caccuri, Francesca; Chlandal, Petr; Wade, Rebecca C.; Paiardi, Giulia; Marco Rusnati, And | |
| direct inhibition of the VEGF/VEGFR system by the Eph/Ephrin antagonist UniPR1331: a new dual-acting antiangiogenic compound | 1-gen-2019 | Chiodelli, P.; Paiardi, G.; Urbinati, C.; Lodola, A.; Tognolini, M.; D'Ursi, P.; Corrado, M.; Rusnati, M. | |
| Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue | 1-gen-2019 | D'Ursi, P.; Uggeri, M.; Urbinati, C.; Millo, E.; Paiardi, G.; Milanesi, L.; Ford, R. C.; Clews, J.; Meng, X.; Bergese, P.; Ridolfi, Andrea; Pedemonte, N.; Fossa, P.; Orro, A.; Rusnati, M. | |
| Glycan-Protein interactions in pathological processes: development of new molecular and cellular models for glycobiology-oriented studies | 25-mar-2021 | Paiardi, Giulia | |
| Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications | 1-gen-2019 | Bugatti, Antonella; Paiardi, Giulia; Urbinati, Chiara; Chiodelli, Paola; Orro, Alessandro; Uggeri, Matteo; Milanesi, Luciano; Caruso, Arnaldo; Caccuri, Francesca; D'Ursi, Pasqualina; Rusnati, Marco | |
| heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications | 1-gen-2019 | Paiardi, G.; Bugatti, A.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Caruso, A.; Caccuri, F.; D'Ursi, P.; Rusnati, M. | |
| Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryos | 1-gen-2024 | Guerra, Jessica; Belleri, Mirella; Paiardi, Giulia; Tobia, Chiara; Capoferri, Davide; Corli, Marzia; Scalvini, Elisa; Ghirimoldi, Marco; Manfredi, Marcello; Wade, Rebecca C.; Presta, Marco; Mignani, Luca | |
| implementation of a new computational protocol based on incremental docking to study interaction of long sugar chain with proteins: heparin/HIV-1 p17 case study | 1-gen-2019 | Paiardi, G.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Milanesi, L.; D'Ursi, P.; Rusnati, M. | |
| implementation of an incremental docking method to study long sugar chains interactions with proteins | 1-gen-2019 | Paiardi, G.; Urbinati, C.; Chiodelli, P.; Orro, A.; Uggeri, M.; Milanesi, L.; Rusnati, M.; D'Ursi, P. | |
| Iron absorption in celiac disease and nutraceutical effect of 7-hydroxymatairesinol. Mini-review | 1-gen-2020 | Zanella, I.; Paiardi, G.; D'Antiga, Lorenzo; Biasiotto, G. | |
| moelcular dynamics simulations to investigate the antiviral effect of heparin in SARS-CoV-2 spike infection | 1-gen-2021 | Paiardi, G.; Richter, S.; Rusnati, M.; Wade, r. c. | |
| Molecular dynamics simulations to investigate the dynamics and mechanism of action of carbohydrate-based polymers | 1-gen-2022 | Paiardi, G; Mukherjee, G; Richter, S; Oreste, P; Urbinati, C; Mukesh, S; Singh, R; Steenbuck, N; Demidova, C; Joshi, P; Rusnati, M; Sangamwar, At; Wade, Rc | |
| multidisciplinary approaches to rescue CFTR impairments by drug repositioning | 1-gen-2019 | Uggeri, M.; Orro, A.; Urbinati, C.; Millo, E.; Paiardi, G.; Milanesi, L.; Pedemonte, N.; Fossa, P.; Rusnati, M.; D'Ursi, P. | |
| rescuing defective CFTR applying a drug repositioning strategy | 1-gen-2019 | Uggeri, M.; Orro, A.; Millo, E.; Cichero, E.; Paiardi, G.; Milanesi, L.; Pedemonte, N.; Rusnati, M.; D'Ursi, P.; Fossa, P. | |
| rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays | 1-gen-2018 | D'Ursi, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Paiardi, G.; Millo, E.; Milanesi, L.; Fossa, P.; Rusnati, M. | |
| rescuing defective CFTR applying a drug repositioning strategy based on computational studies, surface plasmon resonance and cell based assays | 1-gen-2019 | D'Ursi, P.; Orro, A.; Urbinati, C.; Uggeri, M.; Paiardi, G.; Millo, E.; Milanesi, L.; Pedemonte, N.; Fossa, P.; Rusnati, M. | |
| Sialic acid as a target for the development of novel antiangiogenic strategies | 1-gen-2018 | Chiodelli, Paola; Urbinati, Chiara; Paiardi, Giulia; Monti, Eugenio; Rusnati, Marco | |
| Specific profile of ultrasonic communication in a mouse model of neurodevelopmental disorders | 1-gen-2019 | Premoli, M.; Bonini, S. A.; Mastinu, A.; Maccarinelli, G.; Aria, F.; Paiardi, G.; Memo, M. |